期刊文献+

MiR-26b通过靶基因GSK3β调控高糖诱导的系膜细胞肥大 被引量:1

MiR-26b Regulates High Glucose-induced Mesangial Cell Hypertrophy Via Targeting GSK3β
下载PDF
导出
摘要 目的:研究miR-26b调控高糖诱导系膜细胞(MCs)肥大的机制,为其在糖尿病肾病(DN)早期发病机制研究提供新线索。方法:采用生物信息学方法预测调控GSK3β的候选miRNAs;在db/db小鼠肾皮质中验证所有候选miRNAs的表达并分别与GSK3β做pearson相关性分析;以高糖诱导的MCs为载体,采用real-time PCR,观察与GSK3β显著负相关的miRNAs和GSK3β表达水平;转染miR-26b抑制子后,检测高糖诱导的GSK3β以及α-SMA的表达改变。结果:预测到调控GSK3β的候选miRNAs共9个:分别为miR-199a-5p,miR-128,miR-23b,miR-23a,miR-29a,miR-29c,29b,miR-26b,miR-26a;与对照组相比,miR-128,miR-23b,miR-26b,miR-29a,26b在db/db小鼠肾皮质中表达显著上调;其中miR-26b与GSK3β表达水平负相关最显著(r=-0.470 29);高糖诱导的MCs中miR-26b与GSK3β亦呈现显著负相关,miR-26b抑制子部分逆转GSK3β表达水平,同时α-SMA、Ⅳ型胶原表达水平上调。结论:miR-26b可能通过其靶基因GSK3β参与高糖诱导的MCs肥大机制的调控,为DN早期发病机制研究提供了新的思路。 Objective:To investigate mechanism by which miR -26b regulates high glucose-induced mesangial cells (MCs) hypertrophy, providing a novel clue for the insight into diabetic nephropathy (DN) at early stage. Methods:Applying bioinformatics to predict the candidates of miRNAs potentially targeting glycogen synthase kinase -3β (GSK313). To verify the expressions of all of miRNAs candidates in renal cortex of db/db mice and perform pearson relavant analysis between miRNAs and GSK3βrespectively as well. The selected miRNA and GSK313 were detected in MCs exposure to high glucose condition by using real - time PCR . Furthermore, GSK313, hypertrophic gene α - SMA and Collagen IV were detected in MCs cultured in high glucose 72 hours after transfection of selected miRNA inhibitor by real - time PCR and western blot. Results: A total of 9 miRNAs candidates potentially targeting GSK313were screened by bioinformatics, which were miR- 199a- 5p, miR- 128, miR- 23b, miR- 23a, miR- 29a, miR-29c, 29b, miR-26b, miR-26a. Among these candidates, miR-128, miR-23b, miR-26b, miR-29a upregulated remarkably in renal cortex in db/db mice compare with db/m controls (P 〈 0.05 ). One of these four miRNAs, namely miR - 26b showing significantly negative relevance with GSK3 [3by person analysis (r = -0.470 29). The similar results were found in high glucose -induced MCs. The levels of GSK3β were restored partly by transfection of miR -26b inhibitor, meanwhile α-SMA and Collagen IV ameliorated accordingly in cultured MCs in high glucose conditions. Conclusion:Taken together, miR -26b might involve in the regulation of high glucose - induced MCs hypertrophy via targeting GSK3β. The current study provides a novel insight into the pathogenesis of DN at early stage.
出处 《中国中西医结合肾病杂志》 2013年第9期764-768,I0001,共6页 Chinese Journal of Integrated Traditional and Western Nephrology
基金 上海市国际科技合作项目(No.11410708500) 国家自然科学基金面上项目(No.81270814 81270824)
关键词 系膜细胞 肥大 miR-26b GSK3Β 生物信息学 Mesangial cells Hypertrophy MiR - 26b GSK3β Bioinformatics
  • 相关文献

参考文献14

  • 1Mason RM,Wahab NA.Extracellular matrix metabolism in diabetic nephropathy.J Am Soc Nephrol,2003,14(5):1358-1373.
  • 2Satriano J.Kidney growth,hypertrophy and the unifying mechanism of diabetic complications.Amino Acids,2007,33(2):331-339.
  • 3Young BA,Johnson RJ,Alpers CE,et al.Cellular events in the evolution of experimental diabetic nephropathy.Kidney Int,1995,47(3):935-944.
  • 4Kantharidis P,Wang B,Carew RM,et al.Diabetes complications:the microRNA perspective.Diabetes,2011,60(7):1832-1837.
  • 5Zhang Z,Peng H,Chen J,et al.MicroRNA-21 protects from mesangial cell proliferation induced by diabetic nephropathy in db/db mice.FEBS Lett,2009,583(12):2009-2014.
  • 6Long J,Wang Y,Wang W,et al.Identification of microRNA-93 as a novel regulator of vascular endothelial growth factor in hyperglycemic conditions.J Biol Chem,2010,285(30):23457-23465.
  • 7Wang Q,Wang Y,Minto AW,et al.MicroRNA-377 is up-regulated and can lead to increased fibronectin production in diabetic nephropathy.FASEB J,2008,22(12):4126-4135.
  • 8Deng H,Dokshin GA,Goldsmith AM.Inhibition of glocogen sunthase kinase-3β insufficient for airway smooth muscle hypertrophy.J Bio Chem,2008(283):10198-10207.
  • 9高清,刘志红,秦卫松,郑春霞,张明超,曾彩虹,王生余,王建平,朱晓东,黎磊石.雷公藤甲素治疗db/db糖尿病小鼠的疗效观察[J].肾脏病与透析肾移植杂志,2009,18(6):519-528. 被引量:15
  • 10Mogensen CE,Andersen MJ,Increased kidney size and glomerular filtration rate in early juvenile diabetes.Diabetes,1973,22(9):706-712.

二级参考文献39

  • 1宋海翔,龚静,陈雯,王子芬,李延国,左振素.雷公藤多甙对糖尿病肾病患者尿单核细胞趋化蛋白-1的影响[J].中国中西医结合杂志,2005,25(5):416-418. 被引量:47
  • 2Jefferson JA, Shankland SJ, Pichler RH. Proteinuria in diabetic kidney disease : a mechanistic viewpoint. Kidney Int,2008,74( 1 ) :22 - 36.
  • 3Forbes JM, Coughlan MT, Cooper ME. Oxidative stress as a major culprit in kidney disease in diabetes. Diabetes. 2008,57 (6) :1446 -1454.
  • 4Rivero A, Mora C, Muros M ,et al. Palhogenic perspectives for the role of inflammation in diabetic nephropathy. Clin Sci ,2009,116(6):479-492.
  • 5American Diabetes Association. Standards of medical care in diabetes-2007. Diabetes Care,2007,30( Suppl 1 ) :S4 - S41.
  • 6Han SY ,So GA,Jee YH,et al. Effect of retinoic acid in experimental diabetic nephropathy, Immunol Cell Biol, 2004,82 ( 6 ) :568 - 576.
  • 7Brezniceanu ML, Liu F, Wei CC, et al. Catalase overexpression attenuales angintensinogen expression and apoptosis in diabetic mice. Kidney Int,2007,71 (9) :912 - 923.
  • 8Winer S, Chan Y,Paltser G,et al. Normalization of obesity-associated insulin resistance through immunotherapy. Nat Med, 2009, 15 (8) : 921 -929.
  • 9Chen ZH,Qin WS,Zeng CH, et al. Triptolide reduces proteinuria in experimental membranous nephropathy and protects CSb-9-induced podocyte injuries in vitro. Kidney Int. (underreview).
  • 10Zheng CX,Chen ZH, Zeng CH, et al. Triptolide protects podocytcs from puromycinaminonuclcoside induced injory in vivo and in vitro. Kidney Int,2008,74 ( 5 ) :596 - 612.

共引文献14

同被引文献10

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部